Published in Hepatitis Weekly, September 4th, 2000
Therefore, these scientists have developed a synthetic peptide that has a very high sensitivity and specificity that could potentially be used for testing blood donors in Egypt.
Results of this study were presented at the CDC 2000 Internal Conference on Emerging Infectious Diseases, which was hosted by the US Centers for Disease Control and Prevention in Atlanta, Georgia. The report was titled "Synthetic Peptides from Putative Core...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.